RIP 激酶抑制剂;RIP kinase Inhibitors;;InformationGSK3145095 GSK3145095 is a potent and orally active RIP1 kinase inhibitor with IC50 of 6.3 nM with potential antineoplastic and immunomodulatory activities.TargetsRIP1 kinase (Cell-free assay) 6.3 nMIn vitroGSK3145095 potently binds to RIP1 with exquisite kinase specificity and has excellent activity in blocking RIP1 kinasedependent cellular responses. Highlighting its potential as a novel cancer therapy, the inhibitor is also able to promote a tumor suppressive T cell phenotype in pancreatic adenocarcinoma organ cultures.Cell Research(from reference)Cell lines:U937 cells, L-cells NCTC 929 (L929) cells Concentrations:0-3 μM Incubation Time:5 h